After Today’s Huge Increase, Is Emerald Health Therapeutics Inc’s Near-Term Analysis Positive?

 After Today's Huge Increase, Is Emerald Health Therapeutics Inc's Near Term Analysis Positive?

The stock of Emerald Health Therapeutics Inc (CVE:EMH) is a huge mover today! About 390,628 shares traded hands. Emerald Health Therapeutics Inc (CVE:EMH) has risen 6.00% since October 30, 2016 and is uptrending. It has outperformed by 0.74% the S&P500.
The move comes after 8 months positive chart setup for the $86.51M company. It was reported on Nov, 29 by Barchart.com. We have $1.44 PT which if reached, will make CVE:EMH worth $2.60M more.

More recent Emerald Health Therapeutics Inc (CVE:EMH) news were published by: Marketwatch.com which released: “Emerald Health Therapeutics Announces Completion of Private Placement” on November 16, 2016. Also Marketwatch.com published the news titled: “Emerald Health Therapeutics Completes Private Placement and Shares for Debt …” on September 21, 2016. Reuters.com‘s news article titled: “BRIEF-Emerald Health announces no material change” with publication date: May 30, 2016 was also an interesting one.

Emerald Health Therapeutics, Inc., formerly T-Bird Pharma Inc., is a Canada company, which through its subsidiary, Emerald Health Botanicals Inc. , is engaged in the production and sale of medical marihuana. The company has a market cap of $86.51 million. The Company’s segment is production and sales of medical marihuana pursuant to the Marihuana for Medical Purposes Regulations. It currently has negative earnings. Botanicals produces cannabis oils and capsules.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment